Abstract
Protein-protein modulation has emerged as a proven approach to drug discovery. While significant progress has been gained in developing protein-protein interaction (PPI) inhibitors, the orthogonal approach of PPI stabilization lacks established methodologies for drug design. Here, we report the systematic ″bottom-up″ development of a reversible covalent PPI stabilizer. An imine bond was employed to anchor the stabilizer at the interface of the 14-3-3/p65 complex, leading to a molecular glue that elicited an 81-fold increase in complex stabilization. Utilizing protein crystallography and biophysical assays, we deconvoluted how chemical properties of a stabilizer translate to structural changes in the ternary 14-3-3/p65/molecular glue complex. Furthermore, we explore how this leads to high cooperativity and increased stability of the complex.
Original language | English |
---|---|
Pages (from-to) | 8423-8436 |
Number of pages | 14 |
Journal | Journal of Medicinal Chemistry |
Volume | 64 |
Issue number | 12 |
Early online date | 2 Jun 2021 |
DOIs | |
Publication status | Published - 24 Jun 2021 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery